Cargando…
The King is Dead, Long Live the King: Entering A New Era of Stem Cell Research and Clinical Development
In mid November the biopharma industry was shocked by the announcement from Geron that they were ending work on embryonic stem cell research and therapy. For more than 10 years the public image of all stem cell research has been equated with embryonic stem cells. Unfortunately, a fundamentally impor...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3275507/ https://www.ncbi.nlm.nih.gov/pubmed/22185188 http://dx.doi.org/10.1186/1479-5876-9-218 |